0.0001USD0.00%Mkt Cap: 4184 USDP/E: 0.00Last update: 2026-05-22
Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidates include CT-2401, which is in preclinical…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap4.18K USD
Enterprise Value-2.01M USD
Revenue (TTM)52.63M USD
Gross Profit25.28M USD
Net Income (TTM)-60.48M USD
Revenue/Share1.260 USD
Last Price0.0001 USD
Fiscal Year EndDec 2024
MR QuarterSep 2025
Employees46
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.00
PEG—
EV/EBITDA-0.14
EV/Revenue-0.04
P/S0.00
P/B-0.00
EPS (TTM)0.19
EPS (Forward)-0.91
52W Range
0.00010% of range1.270
52W High1.270 USD
52W Low0.0001 USD
Profitability
Gross Margin48.03%
Oper. Margin96.83%
EBITDA Margin26.94%
Profit Margin-308.05%
ROE216.69%
ROA-198.56%
Growth
Revenue Growth1236.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-59.92M USD
CapEx (TTM)123.00K USD
FCF Margin24.79%
FCF Yield311839.75%
Net Debt-2.02M USD
Net Debt/EBITDA-0.14
Balance Sheet
Debt/Equity-0.09
Current Ratio0.86
Quick Ratio0.65
Book Value/Sh-0.0210 USD
Cash/Share0.0660 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 8, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.41.85M
Float30.14M
Insiders26.56%
Institutions10.79%
Short Interest
Short Ratio0.1d
Short % Float3.57%
Short % Out.3.09%
Shares Short1.29M
Short (prev mo.)787.46K
Technical
SMA 500.0179 (-99.4%)
SMA 2000.0883 (-99.9%)
Beta1.31
S&P 52W Chg28.31%
Avg Vol (30d)37.71K
Avg Vol (10d)17.54K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—